Understanding Myeloma

Does Having Private Insurance Instead of Medicare Impact Your Myeloma Care?

Can insurance plans influence patient outcomes? Watch as expert Dr. Kamal Chamoun shares results from a study examining the effects of different types of insurance on myeloma survival.

Published:

Does Race Impact Myeloma Care? An Expert Explains Study From ASCO

Dr. Sikander Ailawadhi spoke on disparities in myeloma data at the 2019 ASCO meeting. Watch as he explains racial, ethnic and social factors that impact myeloma care.

Published:

Advice for People Newly Diagnosed With Myeloma

What do newly diagnosed myeloma patients need to know? During this Patient Café highlight, patients share advice on living well, getting educated and making care decisions.

Published:

How Self-Advocacy Improves Patient-Doctor Communication

How does advocacy work impact cancer care? Tune in to this Myeloma Patient Café as patients discuss ways to help advance myeloma research, improve the patient-doctor relationship and more.

Published:

How Do Doctors Use Information From MRD Testing in Myeloma?

How are minimal residual disease (MRD) test results used? Watch now to hear expert Dr. Elisabet Manasanch discuss FDA-approved methods for MRD testing, optimal timing and value of results in myeloma.

Published:

Will CAR T-Cell Therapy Work for Solid Tumor Cancers?

Is CAR T-cell therapy on the horizon for patients with solid tumor cancers? Watch as Dr. David Maloney discusses advances in CAR-T research, current clinical studies, treatment efficacy and more.

Published:

The ABCs of Clinical Trials With Michele Nadeem-Baker, CLL Patient Advocate

Why should cancer patients consider a clinical trial, and what is the trial care like? Tune in as Phase II CLL clinical trial participant Michele Nadeem-Baker, discusses finding a good trial match and patient safety.

Published:

Is Maintenance Therapy Necessary for MRD-Negative Myeloma Patients?

If a myeloma patient is declared MRD-negative, do they still need maintenance therapy indefinitely? Tune in as Dr. Elisabet Manasanch gives expert advice and explains current research on patients with MRD-negative status.

Published:

Understanding M Protein Level and MRD Testing in Myeloma

What is a good M protein level range for myeloma patients? When is MRD testing recommended? Watch now to hear expert Dr. Elisabet Manasanch explain.

Published:

Showing 9 of 216 programs
Advertisement
Unisciti alla nostra comunità Registrati per eventi Leggi il nostro ultimo blog
Advertisement

Page last updated on June 18, 2019